Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | AZN | AMGN | GILD | VRTX |
| Company | Cellectis S.A. ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.94 | 157.68 | 413.31 | 133.99 | 527.00 |
| High | 3.04 | 159.02 | 418.19 | 137.12 | 531.22 |
| Low | 2.94 | 157.12 | 409.00 | 133.30 | 520.08 |
| Last | 3.03 | 158.83 | 416.24 | 135.96 | 525.76 |
| Change | +0.14 | +0.08 | +1.94 | +0.19 | -3.89 |
| Percent Change | +4.83% | +0.05% | +0.47% | +0.14% | -0.73% |
| Volume | 7,174 | 2,401,633 | 754,727 | 2,591,105 | 422,944 |
| 20-Day Average Volume | 17,534 | 3,832,962 | 2,661,663 | 6,903,266 | 1,353,259 |
| Previous | 2.89 | 158.75 | 414.30 | 135.77 | 529.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.79 | 165.62 | 387.55 | 132.53 | 488.06 |
| 20-Day Raw Stochastic | 100.00% | 23.62% | 89.93% | 63.85% | 73.38% |
| 20-Day Relative Strength | 53.33 | 38.41 | 69.41 | 55.98 | 65.07 |
| Weighted Alpha | -10.34 | -9.05 | +44.85 | +13.61 | +35.68 |
| Today's Opinion | 64% Sell | 100% Sell | 100% Buy | 56% Buy | 100% Buy |
| Yesterday's Opinion | 88% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 56% Buy | 40% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.93% since 08/05/26 | -1.85% since 08/05/26 | +1.84% since 08/05/26 | +3.15% since 08/05/26 | +8.19% since 08/05/26 |
| Low | 2.35 on 08/06/26 | 157.16 on 08/12/26 | 401.07 on 08/07/26 | 129.02 on 08/06/26 | 480.86 on 08/06/26 |
| High | 3.04 on 08/12/26 | 162.93 on 08/06/26 | 421.79 on 08/11/26 | 137.12 on 08/12/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | +1.64% since 07/10/26 | -7.63% since 07/10/26 | +14.30% since 07/10/26 | +4.68% since 07/10/26 | +8.07% since 07/10/26 |
| Low | 2.35 on 08/06/26 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 3.04 on 08/12/26 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | -23.26% since 05/12/26 | -14.10% since 05/12/26 | +23.51% since 05/12/26 | +0.72% since 05/12/26 | +17.01% since 05/12/26 |
| Low | 2.35 on 08/06/26 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 4.19 on 05/14/26 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | -12.92% since 02/12/26 | -22.49% since 02/12/26 | +13.42% since 02/12/26 | -10.47% since 02/12/26 | +12.80% since 02/12/26 |
| Low | 2.35 on 08/06/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 4.55 on 04/13/26 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.95 on 02/13/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 289,980 | 246,206,640 | 223,983,840 | 168,348,672 | 134,427,824 |
| Shares Outstanding, K | 100,339 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 79,590,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -67,590,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 6,900,000 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -21,820,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 2.91 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 08/06/26 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 11/06/26 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.67 | 18.65 | 0.00 | 30.78 |